Royalty Pharma plc
RPRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$464 | $30 | $433 | $334 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | -$1 | $1 | $1 |
| Change in WC | -$712 | $776 | -$64 | $52 |
| Other Non-Cash | $1,815 | -$379 | $227 | $356 |
| Operating Cash Flow | $640 | $427 | $596 | $743 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $1 | -$1 | $0 | $0 |
| Net Acquisitions | -$5 | -$69 | $0 | $0 |
| Inv. Purchases | $76 | -$75 | -$5 | -$496 |
| Inv. Sales/Matur. | $3 | $3 | $523 | $13 |
| Other Inv. Act. | -$975 | -$228 | -$14 | -$22 |
| Investing Cash Flow | -$900 | -$370 | $504 | -$506 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $1,000 | -$292 | -$709 | -$53 |
| Dividends Paid | -$95 | -$93 | -$95 | -$94 |
| Other Fin. Act. | -$337 | -$128 | -$137 | -$112 |
| Financing Cash Flow | $568 | -$513 | -$941 | -$258 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $307 | -$456 | $159 | -$21 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $632 | $1,088 | $929 | $950 |
| End Cash | $939 | $632 | $1,088 | $929 |
| Free Cash Flow | $641 | $427 | $596 | $743 |